Bempedoic Acid Patent Expiration
Bempedoic Acid is Used for lowering LDL-C in patients with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease. It was first introduced by Esperion Therapeutics Inc
Bempedoic Acid Patents
Given below is the list of patents protecting Bempedoic Acid, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nexletol | US11613511 | Methods of making bempedoic acid and compositions of the same | Jun 19, 2040 | Esperion Theraps Inc |
| Nexletol | US11760714 | Methods of making bempedoic acid and compositions of the same | Jun 19, 2040 | Esperion Theraps Inc |
| Nexletol | US11926584 | Methods of making bempedoic acid and compositions of the same | Jun 19, 2040 | Esperion Theraps Inc |
| Nexletol | US11744816 | Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease | Mar 14, 2036 | Esperion Theraps Inc |
| Nexletol | US7335799 | Hydroxyl compounds and compositions for cholesterol management and related uses | Dec 03, 2030 | Esperion Theraps Inc |
| Nexletol | US10118881 | Hydroxyl compounds and compositions for cholesterol management and related uses |
Dec 23, 2023
(Expired) | Esperion Theraps Inc |
| Nexletol | US10941095 | Hydroxyl compounds and compositions for cholesterol management and related uses |
Dec 23, 2023
(Expired) | Esperion Theraps Inc |
| Nexletol | US8497301 | Hydroxyl compounds and compositions for cholesterol management and related uses |
Dec 23, 2023
(Expired) | Esperion Theraps Inc |
| Nexletol | US9000041 | Hydroxyl compounds and compositions for cholesterol management and related uses |
Dec 23, 2023
(Expired) | Esperion Theraps Inc |
| Nexletol | US9624152 | Hydroxyl compounds and compositions for cholesterol management and related uses |
Dec 23, 2023
(Expired) | Esperion Theraps Inc |
Bempedoic Acid's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List